Thursday, 7 January 2016
BRAFV600E mutation testing for thyroid cancer
"The BRAF V600E mutation test is more than 99% specific for thyroid cancer, so a positive result means that it is more than 99% likely that the patient has a malignancy and the entire thyroid can be removed in 1 operation rather than 2. This reduces the risks of complications and shortens the total time spent in hospital and recovery."
BRAFV600E mutation testing for thyroid cancer: avoiding unnecessary surgery
NICE Quality and productivity example
Portsmouth Acute Hospitals NHS Trust
December 2015
Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment